Abstrakt

Przypisy

• 1. Banas J.A.: Virulence properties of Streptococcus mutans. Front.Biosci., 2004; 9: 1267-1277
  Google Scholar
• 2. Benachour A., Ladjouzi R., Le Jeune A., Hébert L., Thorpe S., CourtinP., Chapot-Chartier M.P., Prajsnar T.K., Foster S.J., Mesnage S.:The lysozyme-induced peptidoglycan N-acetylglucosamine deacetylasePgdA (EF1843) is required for Enterococcus faecalis virulence.J. Bacteriol., 2012; 194: 6066-6073 3 Benitez-Paez A., Belda-Ferre P., Simón-Soro A., Mira A.: Microbiotadiversity and gene expression dynamics in human oral biofilms.BMC Genomics, 2014; 15: 311-323
  Google Scholar
• 3. inhibit HIV-1 replication. AIDS, 2003; 17: F39-F48
  Google Scholar
• 4. Brand H.S., Veerman E.C.: Saliva and wound healing. Chin. J.Dent. Res., 2013; 16: 7-12
  Google Scholar
• 5. Brogden K.M., Guthmiller J.M.: Polymicrobial diseases. Washington:ASM Press. 2008
  Google Scholar
• 6. Cirioni O., Giacometti A., Ghiselli R., Orlando F., Kamysz W., D’AmatoG., Mocchegiani F., Lukasiak J., Silvestri C., Saba V., Scalise G.: Potentialtherapeutic role of histatin derivative P-113d in experimental rat modelsof Pseudomonas aeruginosa sepsis. J. Infect. Dis., 2004; 190: 356-364
  Google Scholar
• 7. Dale B.A., Fredericks L.P.: Antimicrobial peptides in the oral environment:expression and function in health and disease. Curr. IssuesMol. Biol., 2005; 7: 119-134
  Google Scholar
• 8. De Smet K., Contreras R.: Human antimicrobial peptides: defensins,cathelicidins and histatins. Biotechnol. Lett., 2005; 27: 1337-1347
  Google Scholar
• 9. Futoma-Kołoch B., Bugla-Płońska G.: Efektywność bakteriobójczegodziałania surowicy wynikająca z obecności układu dopełniacza ilizozymu wobec bakterii, które unikają odpowiedzi immunologicznejorganizmu. Postępy Hig. Med. Dośw., 2009; 63: 471-484
  Google Scholar
• 10. Hatti S., Ravindra S., Satpathy A., Kulkarni R.D., Parande M.V.:Biofilm inhibition and antimicrobial activity of a dentifrice containingsalivary substitutes. Int. J. Dent. Hyg., 2007; 5: 218-224
  Google Scholar
• 11. Helmerhorst E.J., Hodgson R., van’t Hof W., Veerman E.C., AllisonC., Nieuw Amerongen. A.V.: The effects of histatin-derived basic antimicrobialpeptides on oral biofilms. J. Dent. Res., 1999; 78: 1245-1250
  Google Scholar
• 12. Helmerhorst E.J., Troxler R.F., Oppenheim F.G.: The human salivarypeptide histatin 5 exerts its antifungal activity through theformation of reactive oxygen species. Proc. Natl. Acad. Sci. USA,2001; 98: 14637-14642
  Google Scholar
• 13. Huang L., Xu Q.A., Liu C., Fan M.W., Li Y.H.: Anti-caries DNAvaccine-induced secretory immunoglobulin A antibodies inhibitformation of Streptococcus mutans biofilms in vitro. Acta Pharmacol.Sin., 2013; 34: 239-246
  Google Scholar
• 14. Huo L., Zhang K., Ling J., Peng Z., Huang X., Liu H., Gu L.: Antimicrobialand DNA-binding activities of the peptide fragments ofhuman lactoferrin and histatin 5 against Streptococcus mutans. Arch.Oral. Biol., 2011; 56: 869-876
  Google Scholar
• 15. Jankowska A.K., Waszkiel D., Kowalczyk A.: Ślina jako głównyskładnik ekosystemu jamy ustnej. Część I. Mechanizm wydzielaniai funkcje. Wiad. Lek., 2007; 60: 148-154
  Google Scholar
• 16. Joly S., Organ C.C., Johnson G.K., McCray P.B., Guthmiller J.M.:Correlation between β-defensin expression and induction profiles ingingival keratinocytes. Mol. Immunol., 2005; 42: 1073-1084
  Google Scholar
• 17. Kho H.S., Vacca Smith A.M., Koo H., Scott-Anne K., Bowen W.H.:Interactions of Streptococcus mutans glucosyltransferase B with lysozymein solution and on the surface of hydroxyapatite. CariesRes., 2005; 39: 411-416
  Google Scholar
• 18. Klein M.I., DeBaz L., Agidi S., Lee H., Xie G., Lin A.H., HamakerB.R., Lemos J.A., Koo H.: Dynamics of Streptococcus mutans transcriptomein response to starch and sucrose during biofilm development.PLoS One, 2010; 5: e13478
  Google Scholar
• 19. Kolenbrander P.E., Palmer R.J., Rickard A.H., Jakubovics N.S.,Chalmers N.I., Diaz P.I.: Bacterial interactions and successions duringplaque development. Periodontol 2000, 2006; 42: 47-79
  Google Scholar
• 20. Krzyściak W., Jurczak A., Kościelniak D., Bystrowska B., SkalniakA.: The virulence of Streptococcus mutans and the ability to form biofilms.Eur. J. Clin. Microbiol. Infect. Dis., 2014; 33: 499-515
  Google Scholar
• 21. Krzyściak W., Pluskwa K.K., Piątkowski J., Krzyściak P., JurczakA., Kościelniak D., Skalniak A.: The usefulness of biotyping in the determinationof selected pathogenicity determinants in Streptococcusmutans. BMC Microbiol., 2014; 14: 194
  Google Scholar
• 22. Kuboniwa M., Tribble G.D., Hendrickson E.L., Amano A., LamontR.J., Hackett M.: Insights into the virulence of oral biofilms: discoveriesfrom proteomics. Expert Rev. Proteomics, 2012; 9: 311-323
  Google Scholar
• 23. Lang C., Böttner M., Holz C., Veen M., Ryser M., Reindl A., PompejusM., Tanzer J.M.: Specific Lactobacillus/Mutans Streptococcus co–aggregation. J. Dent. Res., 2010; 89: 175-179
  Google Scholar
• 24. Lee S.H., Choi B.K., Kim Y.J.: The cariogenic characters of xylitol-resistantand xylitol-sensitive Streptococcus mutans in biofilmformation with salivary bacteria. Arch. Oral Biol., 2012; 57: 697-703
  Google Scholar
• 25. Lemos J.A., Quivey R.G., Koo H., Abranches J.: Streptococcus mutans:a new Gram-positive paradigm? Microbiology, 2013; 159: 436-445
  Google Scholar
• 26. Leśnierowski G., Borowiak R.: Zastosowanie rezorcyny jako środkaochronnego lizozymu podczas jego wysokotemperaturowej modyfikacji.Żywność. Nauka. Technologia. Jakość, 2012; 2: 131-142
  Google Scholar
• 27. Li R., Kumar R., Tati S., Puri S., Edgerton M.: Candida albicansflu1-mediated efflux of salivary histatin 5 reduces its cytosolic concentrationand fungicidal activity. Antimicrob. Agents Chemother.,2013; 57: 1832-1839
  Google Scholar
• 28. Loesche W.J.: Role of Streptococcus mutans in human dental decay.Microbiol. Rev., 1986; 50: 353-380
  Google Scholar
• 29. Ly-Chatain M.H., Moussaoui S., Vera A., Rigobello V., DemarignyY.: Antiviral effect of cationic compounds on bacteriophages. Front.Microbiol., 2013; 4: 46
  Google Scholar
• 30. Matsui R., Cvitkovitch D.: Acid tolerance mechanisms utilized byStreptococcus mutans. Future Microbiol., 2010; 5: 403-417
  Google Scholar
• 31. Melino S., Santone C., Di Nardo P., Sarkar B.: Histatins: salivarypeptides with copper (II) and zinc(II)-binding motifs. Perspectivesfor biomedical applications. FEBS J., 2014; 281: 657-672
  Google Scholar
• 32. Metwalli K.H., Khan S.A., Krom B.P., Jabra-Rizk M.A.: Streptococcusmutans, Candida albicans, and the human mouth: a sticky situation.PLoS Pathog., 2013; 9: e1003616
  Google Scholar
• 33. Morales J.O., Ross A.C., McConville J.T.: Protein-coated nanoparticlesembedded in films as delivery platforms. J. Pharm. Pharmacol.,2013; 65: 827-838
  Google Scholar
• 34. Nicolas G.G., Lavoie M.C.: Streptococcus mutans and oral streptococciin dental plaque. Can. J. Microbiol., 2011; 57: 1-20
  Google Scholar
• 35. Pasupuleti M., Schmidtchen A., Malmsten M.: Antimicrobialpeptides: key components of the innate immune system. Crit. Rev.Biotechnol., 2012; 32: 143-171
  Google Scholar
• 36. Pepperney A., Chikindas M.: Antibacterial peptides: opportunitiesfor the prevention and treatment of dental caries. ProbioticsAntimicro. Prot., 2011; 3: 68-96
  Google Scholar
• 37. Postollec F., Norde W., de Vries J., Busscher H.J., van der Mei H.C.:Interactive forces between co-aggregating and non-co-aggregatingoral bacterial pairs. J. Dent. Res., 2006; 85: 231-234
  Google Scholar
• 38. Quinones-Mateu M.E., Lederman M.M., Feng Z., Chakraborty B.,Weber J., Rangel H.R., Marotta M.L., Mirza M., Jiang B., Kiser P., Medvik K., Sieg S.F., Weinberg A.: Human epithelial b-defensins 2 and
  Google Scholar
• 39. Rickard A.H., Gilbert P., High N.J., Kolenbrander P.E., HandleyP.S.: Bacterial coaggregation: an integral process in the developmentof multi-species biofilms. Trends Microbiol., 2003; 11: 94-100
  Google Scholar
• 40. Rijnkels M., Elnitski L., Miller W., Rosen J.M.: Multispecies comparativeanalysis of a mammalian-specific genomic domain encodingsecretory proteins. Genomics, 2003; 82: 417-432
  Google Scholar
• 41. Roger V., Tenovuo J., Lenander-Lumikari M., Söderling E., Vilja P.:Lysozyme and lactoperoxidase inhibit the adherence of Streptococcusmutans NCTC 10449 (serotype c) to saliva-treated hydroxyapatite invitro. Caries Res., 1994; 28: 421-428
  Google Scholar
• 42. Sabatini L.M., Warner T.F., Saitoh E., Azen E.A.: Tissue distributionof RNAs for cystatins, histatins, statherin, and proline-richsalivary proteins in humans and macaques. J. Dent. Res., 1989; 68:1138-1145
  Google Scholar
• 43. Samaranayake Y.H., Cheung B.P., Parahitiyawa N., SeneviratneC.J., Yau J.Y., Yeung K.W., Samaranayake L.P.: Synergistic activity oflysozyme and antifungal agents against Candida albicans biofilms ondenture acrylic surfaces. Arch. Oral Biol., 2009; 54: 115-126
  Google Scholar
• 44. Scali C., Kunimoto B.: An update on chronic wounds and the roleof biofilms. J. Cutan. Med. Surg., 2013; 17: 371-376
  Google Scholar
• 45. Senadheera D., Cvitkovitch D.G.: Quorum sensing and biofilmformation by Streptococcus mutans. Adv. Exp. Med. Biol., 2008; 631:178-188
  Google Scholar
• 46. Singh P.K., Parsek M.R., Greenberg E.P., Welsh M.J.: A componentof innate immunity prevents bacterial biofilm development.Nature, 2002; 417: 552-555
  Google Scholar
• 47. Situ H., Bobek L.A.: In vitro assessment of antifungal therapeuticpotential of salivary histatin-5, two variants of histatin-5, andsalivary mucin (MUC7) domain 1. Antimicrob. Agents Chemother.,2000; 44: 1485-1493
  Google Scholar
• 48. Socransky S.S., Haffejee A.D.: Dental biofilms: difficult therapeutictargets. Periodontol. 2000, 2002; 28: 12-55
  Google Scholar
• 49. Söderling E.M., Marttinen A.M., Haukioja A.L.: Probiotic lactobacilliinterfere with Streptococcus mutans biofilm formation in vitro.Curr. Microbiol., 2011; 62: 618-622
  Google Scholar
• 50. Sugiyama K., Suzuki Y., Furuta H.: Isolation and characterizationof histamine-releasing peptides from human parotid saliva.Life Sci., 1985; 37: 475-480
  Google Scholar
• 51. Tati S., Jang W.S., Li R., Kumar R., Puri S., Edgerton M.: Histatin 5resistance of Candida glabrata can be reversed by insertion of Candidaalbicans polyamine transporter-encoding genes DUR3 and DUR31.PLoS One, 2013; 8: e61480
  Google Scholar
• 52. Tati S., Li R., Puri S., Kumar R., Davidow P., Edgerton M.: Histatin5-spermidine conjugates have enhanced fungicidal activity andefficacy as a topical therapeutic for oral candidiasis. Antimicrob.Agents Chemother., 2014; 58: 756-766
  Google Scholar
• 53. Tay W.M., Hanafy A.I., Angerhofer A., Ming L.J.: A plausiblerole of salivary copper in antimicrobial activity of histatin-5-metalbinding and oxidative activity of its copper complex. Bioorg. Med.Chem. Lett., 2009; 19: 6709-6712
  Google Scholar
• 54. Teanpaisan R., Piwat S., Dahlén G.: Inhibitory effect of oral Lactobacillusagainst oral pathogens. Lett. Appl. Microbiol., 2011; 53: 452-459
  Google Scholar
• 55. Vylkova S., Jang W.S., Li W., Nayyar N., Edgerton M.: Histatin 5initiates osmotic stress response in Candida albicans via activationof the Hog1 mitogen-activated protein kinase pathway. Eukaryot.Cell, 2007; 6: 1876-1888
  Google Scholar
• 56. Wan A.K., Seow W.K., Walsh L.J., Bird P.S.: Comparison of fiveselective media for the growth and enumeration of Streptococcusmutans. Aust. Dent. J., 2002; 47: 21-26
  Google Scholar
• 57. Wang G.: Human antimicrobial peptides and proteins. Pharmaceuticals,2014; 7: 545-594
  Google Scholar
• 58. Zijnge V., van Leeuwen M.B., Degener J.E., Abbas F., ThurnheerT., Gmür R., Harmsen H.J.: Oral biofilm architecture on natural teeth.PLoS One, 2010; 5: e9321
  Google Scholar

Pełna treść artykułu